Imagine a room full of current P&T members from across the nation focused on your team and every question you have for them

WE CAN GET YOU IN THAT ROOM

We created Formulary Insights to help biopharmaceutical investors, marketers, and leaders better understand critical payer perceptions of their product and its competitors.

Two%25252520Men%25252520in%25252520Offic

WHAT WE DO

We take you were no one else can

Inside current and Real-World P&T evaluations of any drugs

THEY TRUST US

OUR CLIENTS

We started operations in 2019. Despite the few months we have been in business and the particular environment we all are in, leading pharma corporations have already experienced the value of our insights.  
pfizer.png
greenstone.png
regeneron.jpeg
boehringer ingelheim.png
mylan.jpg
sunonvon.png
Acadia.jpg
Gelesis.jpg
THEY TRUST US

OUR CLIENTS

We started operations in 2019. Despite the few months we have been in business and the particular environment we all are in, leading pharma corporations have already experienced the value of our insights.  
pfizer.png
greenstone.png
regeneron.jpeg
boehringer ingelheim.png
mylan.jpg
sunonvon.png
Acadia.jpg
Gelesis.jpg
Business%20handshake_edited.jpg

HOW WE DO IT

We connect our clients with P&T participants who share their unbiased perspectives on drug labels, clinical trials and other inputs that determine formulary placement.

OUR UNIQUE VALUE PROPOSITION

008-conference.png
OUR PANEL

Only FORMULARY INSIGHTS can identify active P&T committee participants

014-fast-delivery.png
SPEED

Actionable insights in weeks not months

003-rating.png
OUR PEOPLE

Insights interpreted only by those who’ve been there

018-fingerprint-2.png

Studies mirror actual P&T evaluations

023-balance-3.png

Expert panelists perform their analysis away from potential bias

029-flexibility-23.png

Flexible project scopes to accommodate most budgets

NO RETIREES, NO LOOSE AFFILIATIONS, NO MISREPRESENTATIONS

All our panelists are active P&T participants

DIRECT INQUIRY

Multiple-choice and open-text surveying of formulary decision makers

SYNDICATED RESEARCH

To be completed

We solve the fundamental triple-threat to formulary decision maker market research so you can get better access

1

Formulary decision makers are invisible to pharma

We access validated decision makers using compliant and unbiased methods 

You get REAL insights from ACTIVELY practicing formulary decision makers 

THE PROBLEM

THE SOLUTION

THE RESULT

TESTIMONIALS

Pre-launch Study Evaluations gave us the insights that informed Phase 3 study design in time for us to include critical payer endpoints.